Scholars@Duke

International Dermatology Outcome Measures (IDEOM) - Report from the 2022 Annual Meeting.

Publication ,  Journal Article
Lee, K; Woodbury, MJ; Zundell, MP; Aguero, R; Yousif, J; Williams, SC; Rosmarin, D; Silverberg, N; Thiboutot, D; Larocca, C; Shinohara, MM ...
Published in: J Drugs Dermatol
December 1, 2023
Published version (DOI) Link to item

BACKGROUND: The International Dermatology Outcome Measures (IDEOM) is a non-profit organization dedicated to the advancement of evidence-based, consensus-driven outcome measures in dermatological diseases. Researchers and stakeholders from various backgrounds collaborate to develop these objective benchmark metrics to further advance treatment and management of dermatological conditions. SUMMARY: The 2022 IDEOM Annual Meeting was held on June 17-18, 2022. Leaders and stakeholders from the hidradenitis suppurativa, acne, vitiligo, actinic keratosis, alopecia areata, itch, cutaneous lymphoma, and psoriatic disease workgroups discussed the progress of their respective outcome-measures research. This report summarizes each workgroup's updates from 2022 and their next steps as established during the 2022 IDEOM Annual Meeting. J Drugs Dermatol. 2023;22(12):1153-1159 doi:10.36849/JDD.7615.

Duke Scholars

Tarannum Jaleel
Author Tarannum Jaleel Dermatology

Published In

J Drugs Dermatol

DOI

10.36849/JDD.7615

ISSN

1545-9616

Publication Date

December 1, 2023

Volume

22

Issue

12

Start / End Page

1153 / 1159

Location

United States

Related Subject Headings

  • Skin Neoplasms
  • Psoriasis
  • Outcome Assessment, Health Care
  • Humans
  • Dermatology
  • Alopecia Areata
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lee, K., Woodbury, M. J., Zundell, M. P., Aguero, R., Yousif, J., Williams, S. C., … Gottlieb, A. B. (2023). International Dermatology Outcome Measures (IDEOM) - Report from the 2022 Annual Meeting. J Drugs Dermatol, 22(12), 1153–1159. https://doi.org/10.36849/JDD.7615
Lee, Kathryn, Michael J. Woodbury, Melissa Peri Zundell, Rosario Aguero, Jenna Yousif, Samuel Clay Williams, David Rosmarin, et al. “International Dermatology Outcome Measures (IDEOM) - Report from the 2022 Annual Meeting.” J Drugs Dermatol 22, no. 12 (December 1, 2023): 1153–59. https://doi.org/10.36849/JDD.7615.
Lee K, Woodbury MJ, Zundell MP, Aguero R, Yousif J, Williams SC, et al. International Dermatology Outcome Measures (IDEOM) - Report from the 2022 Annual Meeting. J Drugs Dermatol. 2023 Dec 1;22(12):1153–9.
Lee, Kathryn, et al. “International Dermatology Outcome Measures (IDEOM) - Report from the 2022 Annual Meeting.” J Drugs Dermatol, vol. 22, no. 12, Dec. 2023, pp. 1153–59. Pubmed, doi:10.36849/JDD.7615.
Lee K, Woodbury MJ, Zundell MP, Aguero R, Yousif J, Williams SC, Rosmarin D, Silverberg N, Thiboutot D, Larocca C, Shinohara MM, Mostaghimi A, Stander S, Martorell A, Jaleel T, Torbeck RL, Siegel DM, Perez-Chada L, Strand V, Armstrong AW, Merola JF, Gottlieb AB. International Dermatology Outcome Measures (IDEOM) - Report from the 2022 Annual Meeting. J Drugs Dermatol. 2023 Dec 1;22(12):1153–1159.

Published In

J Drugs Dermatol

DOI

10.36849/JDD.7615

ISSN

1545-9616

Publication Date

December 1, 2023

Volume

22

Issue

12

Start / End Page

1153 / 1159

Location

United States

Related Subject Headings

  • Skin Neoplasms
  • Psoriasis
  • Outcome Assessment, Health Care
  • Humans
  • Dermatology
  • Alopecia Areata